Huang Hui-Qiang相关文献与解析，生知库 | 链接生命科学的每一步

Li, Shuo; Gao, Li-Min; Hong, Huang-Ming; Zhong, Yu-Jia; Cai, Qing-Qing; Huang, Hui-Qiang; Li, Zhi-Ming; Huang, He; Zheng, Yin-Li; Zeng, Xuan-Kai; Feng, Yan-Fen; Zhang, Ying-Chun; Zang, Sheng-Bing; Li, Yan; Yun, Jing-Ping; Huang, Yu-Hua

T细胞

淋巴瘤

T细胞

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults

relmacabtagene autoleucel（CD19 CAR-T）治疗中国成人复发/难治性套细胞淋巴瘤的II期研究

期刊:Blood Advances

影响因子:7.1

doi:10.1182/bloodadvances.2024015763

Xie, Yan; Zhou, Ke-Shu; Li, Lan-Fang; Liang, Ai-Bin; Mei, Heng; Zou, De-Hui; Li, Wen-Yu; Jin, Jie; Jin, Zheng-Ming; Jing, Hong-Mei; Yang, Hai-Yan; Chen, Tong; Huang, Hui-Qiang; He, Peng-Cheng; Cao, Jun-Ning; Xia, Zhen; Gu, Yong-En; Zang, Yi-Bei; Zhou, Zi-Song; Tian, Zhao-Zhao; Zhu, Jun; Song, Yu-Qin

Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study

血清甘油三酯和载脂蛋白A1作为结外NK/T细胞淋巴瘤（ENKTL）的动态生物标志物：一项多中心回顾性和前瞻性验证研究

期刊:Annals of Hematology

影响因子:2.4

doi:10.1007/s00277-025-06724-0

Wang, Jin-Ni; Xiong, Jie; Guo, Han-Guo; Li, Zhi-Hua; Cao, Yi; Fang, Yu; Liu, Yu-Ying; Li, Yan-Hong; Cai, Jun; Zhang, Yu-Chen; Zou, Qi-Hua; Wang, Jia-Hui; Xia, Yi; Huang, Hui-Qiang; Sun, Chang-Gang; Li, Song-Qi; Wang, Liang; Zhao, Wei-Li; Cai, Qing-Qing

Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma

格洛菲单抗单药治疗在中国既往接受过大量治疗的复发或难治性弥漫性大B细胞淋巴瘤患者中可诱导较高的完全缓解率和可控的安全性。

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2023.283802

Song, Yu-Qin; Zhang, Hui-Lai; Huang, Hui-Qiang; Zhang, Qing-Yuan; Jing, Hong-Mei; Wang, Chao; Wu, Chun; Li, Dong-Hang; Dai, Yu; Humphrey, Kathryn; Zhu, Jun

Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma

优化化疗药物联合放疗治疗结外NK/T细胞淋巴瘤

期刊:Therapeutic Advances in Medical Oncology

影响因子:4.2

doi:10.1177/17588359241285981

Luo, Fei; Zhong, Qiu-Zi; Liu, Xin; Hou, Xiao-Rong; Qian, Li-Ting; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Qu, Bao-Lin; Yang, Yong; Hu, Chen; Deng, Min; Wang, Shu-Lian; Qi, Shu-Nan; Li, Ye-Xiong

Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database

当前治疗方法治愈结外鼻型自然杀伤/T细胞淋巴瘤的证据：CLCG数据库分析

期刊:Haematologica

影响因子:7.9

doi:10.3324/haematol.2022.281847

Liu, Xin; Zhang, Li-Ling; Qu, Bao-Lin; Zhong, Qiu-Zi; Qian, Li-Ting; Yang, Yong; Hou, Xiao-Rong; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; Chen, Fan; Yin, Lin; He, Xia; Cai, Shang; Li, Ye-Xiong; Qi, Shu-Nan

Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells

半乳糖凝集素-9促进人类B细胞中的爱泼斯坦-巴尔病毒潜伏感染和淋巴瘤形成

期刊:Microbiology Spectrum

影响因子:3.7

doi:10.1128/spectrum.04932-22

Jing-Xiao Xu #, Rong Zhang #, Dai-Jia Huang, Ying Tang, Li-Qin Ping, Bi-Jun Huang, Hui-Qiang Huang, Pierre Busson, Jiang Li

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

CLCG研究中结外自然杀伤/T细胞淋巴瘤患者早期进展的结局和风险预测

期刊:Annals of Hematology

影响因子:2.4

doi:10.1007/s00277-023-05311-5

Li, Jia-Ying; Hou, Xiao-Rong; Chen, Si-Ye; Liu, Xin; Zhong, Qiu-Zi; Qian, Li-Ting; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Qu, Bao-Lin; Yang, Yong; Hu, Chen; Deng, Min; Wang, Shu-Lian; Qi, Shu-Nan; Li, Ye-Xiong

Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database

来自中国淋巴瘤协作组数据库的早期结外鼻型自然杀伤/T细胞淋巴瘤原发治疗后远处转移的特征和预后

期刊:eJHaem

影响因子:1.2

doi:10.1002/jha2.613

Zheng, Xuan; Qu, Bao-Lin; Liu, Xin; Zhong, Qiu-Zi; Qian, Li-Ting; Yang, Yong; Hou, Xiao-Rong; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; Chen, Fan; Yin, Lin; He, Xia; Zhang, Li-Ling; Li, Ye-Xiong; Qi, Shu-Nan

Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

更正：结外NK/T细胞淋巴瘤患者24个月无进展生存期及后续生存期：中国淋巴瘤协作组（CLCG）研究

期刊:Leukemia

影响因子:13.4

doi:10.1038/s41375-021-01371-6

Yang, Yong; Wang, Ying; Liu, Xin; He, Xia; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Hu, Chen; Qi, Shu-Nan; Li, Ye-Xiong

Development and validation of a predictive model for extranodal natural killer/T-cell lymphoma

结外自然杀伤/T细胞淋巴瘤预测模型的建立与验证

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults

relmacabtagene autoleucel（CD19 CAR-T）治疗中国成人复发/难治性套细胞淋巴瘤的II期研究

Serum triglyceride and apolipoprotein A1 as dynamic biomarkers in extranodal NK/T-cell lymphoma (ENKTL): A multicenter retrospective and prospective validation study

血清甘油三酯和载脂蛋白A1作为结外NK/T细胞淋巴瘤（ENKTL）的动态生物标志物：一项多中心回顾性和前瞻性验证研究

Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma

格洛菲单抗单药治疗在中国既往接受过大量治疗的复发或难治性弥漫性大B细胞淋巴瘤患者中可诱导较高的完全缓解率和可控的安全性。

Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma

优化化疗药物联合放疗治疗结外NK/T细胞淋巴瘤

Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database

当前治疗方法治愈结外鼻型自然杀伤/T细胞淋巴瘤的证据：CLCG数据库分析

Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells

半乳糖凝集素-9促进人类B细胞中的爱泼斯坦-巴尔病毒潜伏感染和淋巴瘤形成

Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study

CLCG研究中结外自然杀伤/T细胞淋巴瘤患者早期进展的结局和风险预测

Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database

来自中国淋巴瘤协作组数据库的早期结外鼻型自然杀伤/T细胞淋巴瘤原发治疗后远处转移的特征和预后

Correction to: Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

更正：结外NK/T细胞淋巴瘤患者24个月无进展生存期及后续生存期：中国淋巴瘤协作组（CLCG）研究